Thermo Fisher Scientific
Price data unavailable
Track TMO in your trading journalAbout Thermo Fisher Scientific
Thermo Fisher Scientific (Nasdaq/NYSE: TMO) is a Life Sciences Tools & Services company operating within the Health Care sector of the US equity market.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
The company reports trailing twelve-month revenue of $5.85B and net income of $1.65B.
Key metrics include a return on equity of 3.2%.
Use FINOTAUR to track TMO's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $5.85B |
| Net Income (TTM) | $1.65B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 3.18% |
| Debt-to-Equity | — |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 26
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- GlobeNewswire Inc.·May 21
Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence
- Benzinga·May 18
Dan Loeb Dumps Microsoft, Slashes Nvidia And Rail Stocks In Sweeping Q1 Portfolio Overhaul
Want real-time analysis on TMO?
Track it free in your trading journal. Log trades, tag setups, and review your edge.